Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635), is pleased to...
New global CDMO combines commercial spray drying and particle engineering technologies under one brand. Codis officially launches as a new global CDMO specializing in commercial-scale...
ENCell, a leading biopharmaceutical company for cell and gene therapy CDMO and novel drug development, announced today that its investigational drug EN001 has been granted...